• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价一种用于检测心内膜炎患者心瓣膜组织中病原体的多重实时 PCR 检测方法。

Evaluation of a multiplex real-time PCR assay for detecting pathogens in cardiac valve tissue in patients with endocarditis.

机构信息

Servicio de Cirugía Cardiaca, Hospital Clínico Universitario, Santiago de Compostela, A Coruña, España.

出版信息

Rev Esp Cardiol. 2010 Oct;63(10):1205-8. doi: 10.1016/s1885-5857(10)70236-x.

DOI:10.1016/s1885-5857(10)70236-x
PMID:20875362
Abstract

With a novel real-time multiplex polymerase chain reaction test, the LightCycler SeptiFast® test, 25 bacterial and fungal species can be identified directly in blood. The SeptiFast® test has been used for rapid etiologic diagnosis in infectious endocarditis using blood samples but has not been evaluated directly on cardiac vegetations in patients being treated for infectious endocarditis. We prospectively analyzed 15 samples of heart valve tissue with active infectious endocarditis using the SeptiFast® test and compared the test's sensitivity with that of blood culture, valve tissue culture, and the SeptiFast® test in blood. The sensitivity of the SeptiFast test in heart valve tissue was 100%. The test results confirmed the diagnosis obtained using blood culture in 13 cases and identified the pathogen in 2 cases where blood culture tested negative. The sensitivity of the SeptiFast® test in heart valve tissue was greater than that obtained with conventional culture of vegetations or with the SeptiFast test in blood.

摘要

采用新型实时多重聚合酶链反应检测技术——LightCycler SeptiFast®检测,可直接从血液中鉴定 25 种细菌和真菌种类。SeptiFast®检测已用于感染性心内膜炎的快速病因诊断,采用的是血样标本,但尚未直接在接受感染性心内膜炎治疗的患者的心脏赘生物上进行评估。我们前瞻性地分析了 15 例患有活动性感染性心内膜炎的心脏瓣膜组织样本,采用 SeptiFast®检测,并将该检测的敏感性与血培养、瓣膜组织培养以及血液中的 SeptiFast®检测进行比较。SeptiFast 检测在心脏瓣膜组织中的敏感性为 100%。检测结果在 13 例中证实了血培养获得的诊断,并在 2 例血培养阴性的病例中确定了病原体。与传统的瓣膜组织培养或血液中的 SeptiFast 检测相比,SeptiFast®检测在心脏瓣膜组织中的敏感性更高。

相似文献

1
Evaluation of a multiplex real-time PCR assay for detecting pathogens in cardiac valve tissue in patients with endocarditis.评价一种用于检测心内膜炎患者心瓣膜组织中病原体的多重实时 PCR 检测方法。
Rev Esp Cardiol. 2010 Oct;63(10):1205-8. doi: 10.1016/s1885-5857(10)70236-x.
2
A commercially available multiplex real-time PCR for detection of pathogens in cardiac valves from patients with infective endocarditis.一种用于检测感染性心内膜炎患者心脏瓣膜中病原体的市售多重实时聚合酶链反应。
Diagn Microbiol Infect Dis. 2014 May;79(1):98-101. doi: 10.1016/j.diagmicrobio.2013.12.011. Epub 2013 Dec 21.
3
Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnostic of infectious endocarditis.LightCycler SeptiFast检测在感染性心内膜炎快速病因诊断中的评估
Eur J Clin Microbiol Infect Dis. 2009 Jun;28(6):569-73. doi: 10.1007/s10096-008-0672-6. Epub 2008 Dec 2.
4
The diagnostic benefit of 16S rDNA PCR examination of infective endocarditis heart valves: a cohort study of 146 surgical cases confirmed by histopathology.16S rDNA PCR 检查对感染性心内膜炎心瓣膜的诊断益处:经组织病理学证实的 146 例手术病例的队列研究。
Clin Res Cardiol. 2021 Mar;110(3):332-342. doi: 10.1007/s00392-020-01678-x. Epub 2020 Jun 2.
5
Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue.通过实时宽范围聚合酶链反应(PCR)并直接从心脏瓣膜组织进行测序对感染性心内膜炎进行分子诊断。
Medicine (Baltimore). 2007 Jul;86(4):195-202. doi: 10.1097/MD.0b013e31811f44ec.
6
Broad-Range 16S rDNA PCR on Heart Valves in Infective Endocarditis.感染性心内膜炎心脏瓣膜的广谱16S核糖体DNA聚合酶链反应
J Heart Valve Dis. 2016 Mar;25(2):221-226.
7
Diagnosis of infectious endocarditis in patients undergoing valve surgery.接受瓣膜手术患者感染性心内膜炎的诊断
Am J Med. 2005 Mar;118(3):230-8. doi: 10.1016/j.amjmed.2004.12.014.
8
Clinical Significance of a 16S-rDNA Analysis of Heart Valves in Patients with Infective Endocarditis: a Retrospective Study.心脏瓣膜感染性心内膜炎患者 16S-rDNA 分析的临床意义:一项回顾性研究。
Microbiol Spectr. 2023 Jun 15;11(3):e0113623. doi: 10.1128/spectrum.01136-23. Epub 2023 May 17.
9
Rapid qualitative urinary tract infection pathogen identification by SeptiFast real-time PCR.SeptiFast 实时 PCR 快速定性尿路感染病原体鉴定。
PLoS One. 2011 Feb 16;6(2):e17146. doi: 10.1371/journal.pone.0017146.
10
A broad-range PCR technique for the diagnosis of infective endocarditis.一种用于诊断感染性心内膜炎的广谱聚合酶链反应技术。
Braz J Microbiol. 2018 Jul-Sep;49(3):534-543. doi: 10.1016/j.bjm.2017.03.019. Epub 2018 Feb 9.

引用本文的文献

1
From Culture-Negative to DNA-Positive: The Molecular Revolution in Infective Endocarditis Diagnosis.从培养阴性到DNA阳性:感染性心内膜炎诊断的分子革命
Pathogens. 2025 May 23;14(6):518. doi: 10.3390/pathogens14060518.
2
Rapid Microbiological Diagnostics from Explanted Heart Valves by a Multiplex PCR Assay.通过多重聚合酶链反应检测法对取出的心脏瓣膜进行快速微生物诊断
J Clin Microbiol. 2019 Jan 30;57(2). doi: 10.1128/JCM.01575-18. Print 2019 Feb.
3
Identification and Antibiotic-Susceptibility Profiling of Infectious Bacterial Agents: A Review of Current and Future Trends.
鉴定和药敏分析传染性细菌病原体:当前和未来趋势综述。
Biotechnol J. 2019 Jan;14(1):e1700750. doi: 10.1002/biot.201700750. Epub 2018 Aug 26.
4
Blood culture-negative endocarditis: Improving the diagnostic yield using new diagnostic tools.血培养阴性的心内膜炎:使用新诊断工具提高诊断率
Medicine (Baltimore). 2017 Nov;96(47):e8392. doi: 10.1097/MD.0000000000008392.
5
Beyond Blood Culture and Gram Stain Analysis: A Review of Molecular Techniques for the Early Detection of Bacteremia in Surgical Patients.超越血培养和革兰氏染色分析:外科患者菌血症早期检测分子技术综述
Surg Infect (Larchmt). 2016 Jun;17(3):294-302. doi: 10.1089/sur.2015.099. Epub 2016 Feb 26.
6
Multiplex PCR performed of bronchoalveolar lavage fluid increases pathogen identification rate in critically ill patients with pneumonia: a pilot study.对支气管肺泡灌洗液进行多重 PCR 可提高危重症肺炎患者的病原体检出率:一项初步研究。
Ann Intensive Care. 2014 Nov 25;4:35. doi: 10.1186/s13613-014-0035-7. eCollection 2014.
7
Molecular diagnosis of sepsis: New aspects and recent developments.脓毒症的分子诊断:新进展与近期动态
Eur J Microbiol Immunol (Bp). 2014 Mar;4(1):1-25. doi: 10.1556/EuJMI.4.2014.1.1. Epub 2014 Mar 14.
8
New approaches to sepsis: molecular diagnostics and biomarkers.新的脓毒症治疗方法:分子诊断和生物标志物。
Clin Microbiol Rev. 2012 Oct;25(4):609-34. doi: 10.1128/CMR.00016-12.
9
Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier?从 bench 到床边的综述:血流感染的快速分子诊断——一个新领域?
Crit Care. 2012 May 29;16(3):222. doi: 10.1186/cc11202.